InvestorsHub Logo
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: z1z2z3 post# 113

Tuesday, 07/03/2018 7:17:27 AM

Tuesday, July 03, 2018 7:17:27 AM

Post# of 330
Antibe Therapeutics Releases Secondary Endpoint Data from Recent Phase 2B Gastrointestinal Safety Study for Lead Drug, ATB-346https://finance.yahoo.com/news/antibe-therapeutics-releases-secondary-endpoint-110000421.html

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"